文献速递神经MRPET

胶质母细胞瘤高级神经影像的挑战与机遇

Challenges and opportunities for advanced neuroimaging of glioblastoma.
PubMed 文献 · Br J Radiol · 2022-10-14

本文综述了扩散加权MRI、灌注加权MRI、MR波谱和PET等高级成像技术在胶质母细胞瘤首次诊断、治疗计划和随访中的应用。这些技术的半定量分析有助于评估肿瘤侵袭性和范围,并辅助区分肿瘤进展与治疗相关效应,但目前尚无明确的成像策略,且缺乏统一指南。人工智能工具有望通过自动化肿瘤测量和预测基因型来增强神经放射学实践。

要点

  • 高级成像的半定量分析有助于评估肿瘤侵袭性和范围。
  • 有助于鉴别肿瘤进展与治疗相关效应。
  • 目前尚无统一成像策略,缺乏标准化指南。

核心结论

  • 高级成像技术的半定量分析对评估胶质母细胞瘤侵袭性和范围有用,并有助于区分肿瘤进展与治疗相关效应。
  • 目前尚无明确的成像策略,且缺乏统一指南,标准化不足阻碍了指南制定。

研究设计与样本

  • 综述,旨在教育读者关于高级成像技术临床应用的优缺点。

关键影像表现/征象

  • 常规MR上,胶质母细胞瘤表现为不规则强化病灶,伴浸润性肿瘤区域和皮层扩张。

临床应用与阅片要点

  • 高级成像工具的半定量分析可用于评估肿瘤侵袭性和范围,并辅助鉴别肿瘤进展与治疗相关效应。
  • 人工智能工具有望自动化肿瘤测量等劳动密集型任务,并提供预测肿瘤基因型等额外诊断信息。

局限性

  • 高级成像和人工智能诊断未纳入反应评估标准,缺乏统一使用指南。
  • 缺乏标准化严重阻碍了统一指南的定义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Glioblastoma is the most aggressive of glial tumours in adults. On conventional magnetic resonance (MR) imaging, these tumours are observed as irregular enhancing lesions with areas of infiltrating tumour and cortical expansion. More advanced imaging techniques including diffusion-weighted MRI, perfusion-weighted MRI, MR spectroscopy and positron emission tomography (PET) imaging have found widespread application to diagnostic challenges in the setting of first diagnosis, treatment planning and follow-up. This review aims to educate readers with regard to the strengths and weaknesses of the clinical application of these imaging techniques. For example, this review shows that the (semi)quantitative analysis of the mentioned advanced imaging tools was found useful for assessing tumour aggressiveness and tumour extent, and aids in the differentiation of tumour progression from treatment-related effects. Although these techniques may aid in the diagnostic work-up and (post-)treatment phase of glioblastoma, so far no unequivocal imaging strategy is available. Furthermore, the use and further development of artificial intelligence (AI)-based tools could greatly enhance neuroradiological practice by automating labour-intensive tasks such as tumour measurements, and by providing additional diagnostic information such as prediction of tumour genotype. Nevertheless, due to the fact that advanced imaging and AI-diagnostics is not part of response assessment criteria, there is no harmonised guidance on their use, while at the same time the lack of standardisation severely hampers the definition of uniform guidelines.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Henssen, Meijer, Verburg, et al. Challenges and opportunities for advanced neuroimaging of glioblastoma. Br J Radiol. 2022. PMID: 36062962. doi:10.1259/bjr.20211232

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。